Biocure Enters into Exclusive Joint R&D Agreement with Pharos Vaccine Inc. for Overseas Market of CAR T-Cell Products Biotech Investing
Green Growth Brands Completes 27.3 Million Share Buyback and Cancels 13% of Outstanding Shares Cannabis Investing News
Turning Point Therapeutics Announces FDA Clearance of Investigational New Drug Application Pharmaceutical Investing
Auris Medical Closes Two US Patent Acquisitions Related to the Use of Betahistine for the Treatment of Depression and ADHD Pharmaceutical Investing
MediPharm Labs Signs Committed Term Sheet for $20 Million Debt Facility With Schedule 1 Bank Cannabis Investing News
Lexaria’s DehydraTECHTM Formulation Delivers 475% More CBD to Bloodstream after 15 Minutes than Conventional Industry Formulations Cannabis Investing News